XML 30 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Sale of Sumavel DosePro Business Net Assets and Calculation of Gain on Sale (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
May 16, 2014
Sumavel DosePro
Sep. 30, 2014
Sumavel DosePro
May 16, 2014
Sumavel DosePro
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Non-contingent consideration received               $ 89,624
Imputed interest on working capital advance               4,748
Carrying value of Sumavel DosePro inventory on hand at Closing 5,901   5,901   1,112     (4,624)
Transaction costs               (660)
Deferred revenue associated with undelivered elements             (8,863) (9,108)
Net gain on sale of business $ 0 $ 0 $ 79,980 $ 0   $ 79,980 $ 79,980